Greenland Mines Ltd. (GRML)
NASDAQ: GRMLHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
GRML stock chart
Technical analysisKey statistics
All statistics- Market cap
- $44.31M
- EPS (TTM)
- -$9.74
- Dividend yield
- None
- 52-week range
- 2.75 – 37.00
- Day range
- 2.75 – 3.10
- Volume / Avg
- 857.85K / 8.93M
- Beta
- —
- Shares outstanding
- 14.82M
52-week range
GRML stock today
Shares of Greenland Mines (GRML) finished higher on Nov 20 at $2.99, a gain of 2.75% or $0.08 per share, versus the S&P 500's 3.70% decline. Trading was light, with 857.85K shares changing hands, about 10% of the average daily volume. At this level, GRML sits near the bottom of its 52-week range of $2.75 to $37.00: 91.9% below the high, set on Mar 4, 2026 and 8.7% above the low.
GRML is down 79.3% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 87.1%. Greenland Mines has posted a net loss over the last twelve months (EPS of -$9.74), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Greenland Mines
Company profileGreenland Mines Ltd engages in the cell and gene therapy, and natural resources businesses. The company primarily explores palladium, gold, and platinum deposits. It focuses on the exploration and development of Skaergaard project located in Southeast Greenland and the Sarartoq neodymium-praseodymium (Nd-Pr) rare earths project in Southwest Greenland.
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- CEO
- Dr. Joseph A. Sinkule Pharm.D.
- Headquarters
- Charlotte, NC
- Employees
- 5
- IPO year
- 2022
- Website
- greenlandmines.com
Financial highlights
Full financialsGreenland Mines reported a net loss of $10.6 million, compared with a loss of $6.2 million a year earlier. Diluted earnings per share came in at -$0.22.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Revenue | — | — | — | — |
| Growth | — | — | — | — |
| Net income | $-10.55M | $-6.15M | $-707.46K | $1.23M |
| EPS (diluted) | $-0.22 | $-0.32 | $-0.05 | — |
Analyst forecast
ForecastConsensus (1 analysts)
none
Avg. price target
$110.00+3578.93%
- Strong buy 0
- Buy 1
- Hold 0
- Sell 0
- Strong sell 0
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 16, 2026
- EPS actual vs est.
- $-2.51 vs —
GRML news
All GRML news- Greenland Mines Ltd Provides Early Warning Disclosure Regarding AnorTech Inc.GlobeNewswire
- Greenland Mines Welcomes Greenland Parliament’s Approval of Landmark U.S.-Denmark-Greenland Security AgreementGlobeNewswire
- Greenland Mines Shares Begin Trading on Xetra in GermanyGlobeNewswire
- Greenland Mines Applauds President Trump’s Focus on Greenland Mineral Exploration, Reinforcing Its Importance to U.S. and Allied SecurityGlobeNewswire
- Greenland Mines Welcomes EU Selection of Neo Performance Materials’ Silmet 2.0 as Strategic Project; Highlights Sarfartoq’s Potential Role in Secure Transatlantic Rare Earth SupplyGlobeNewswire
- Greenland Mines President Invited to Join Global Business and Policy Leaders at 2026 Arctic Circle Assembly and Mining RoundtableGlobeNewswire
Greenland Mines peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ELOXEloxx Pharmaceuticals Inc. | 10.69 | -1.75% | $43.69M | vs GRML |
| INKTMiNK Therapeutics Inc. | 8.02 | -6.85% | $41.17M | vs GRML |
| ELUTElutia Inc. Class A | 0.9001 | +11.12% | $39.96M | vs GRML |
| IMAImageneBio Inc. | 3.92 | 0.00% | $48.83M | vs GRML |
| TILInstil Bio Inc. | 5.23 | -5.77% | $35.47M | vs GRML |
| AVXLAnavex Life Sciences Corp. | 0.5915 | -11.39% | $54.83M | vs GRML |
| CGTXCognition Therapeutics Inc. | 0.5822 | -3.06% | $55.37M | vs GRML |
| OKYOOKYO Pharma Limited | 1.07 | -7.76% | $56.15M | vs GRML |
Indexes, lists and sector
Greenland Mines stock FAQ
What is Greenland Mines's stock price today?
GRML last traded at $2.99 as of Nov 20, 4:00 PM EST, up 2.75% on the day. Prices are delayed at least 15 minutes.
Does Greenland Mines pay a dividend?
No. Greenland Mines does not currently pay a regular cash dividend.
Who is Greenland Mines's CEO?
Dr. Joseph A. Sinkule Pharm.D. is the chief executive officer of Greenland Mines Ltd., which has about 5 employees.
Has GRML ever split its stock?
Yes. The most recent GRML stock split was a 1-for-50 split on Aug 24, 2026.
What is the GRML 52-week high?
The 52-week high for GRML is $37.00 and the 52-week low is $2.75. The stock is currently 91.9% below its high.